Skip to main content

Oregon State Flag An official website of the State of Oregon »

Prescription Drug Affordability Board (PDAB)

Do you think your prescription drugs cost too much?

The Prescription Drug Affordability Board is hosting community forums around the state. Come and learn why drug costs are so high and help us identify solutions. Come share your story with board staff about how medication costs have affected your health, budget, and life. Take the survey located on the PDAB website.
Click here for a flyer. Haga clic aquí para obtener información en espanol.

    In person forums
  • Portland – April 2
  • Lincoln City – April 9
  • Woodburn – April 15
  • Medford – April 25, 6-8 p.m.
    Rogue Community College HEC
    Riverside Presentation Hall, 101 S Bartlett Street
    American Sign Language provided
    Bend – April 30, 6-8 p.m.
  • East Bend Library, 62080 Dean Swift Road

  • Online forums
  • May 8, Noon to 2 p.m.
    Join ZoomGov Meeting https://www.zoomgov.com/j/1609683098?pwd=ZFVvNHdGV1dMYm5GWWQ1ZWlkcEl4UT09
    Meeting ID: 160 968 3098
    Passcode: OregonPDAB
    Dial by your location: 669 254 5252
    Interpretación en español
    Spanish and American Sign Language interpretation provided

  • May 14, 6-8 p.m.
    Join ZoomGov Meeting https://www.zoomgov.com/j/1617060370?pwd=YlhObURQRTcyTTJrSkx2ZjB0S3RUUT09
    Meeting ID: 161 706 0370
    Passcode: OregonPDAB
    Dial by your location: 669 254 5252
    Interpretación en español
    Spanish and American Sign Language interpretation provided

The next PDAB meeting is:

Wednesday, May 15, 2024
9:30 A.M. Pacific Time

Register here 

Meeting agenda  

Agenda packet 

About the PDAB

The Prescription Drug Affordability Board is established in the Department of Consumer and Business Services under ORS 646A.693 to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon and others within the health care system in this state from the high costs of prescription drugs. To learn more about the board’s work,see the FAQ page.